Anti-Valproic Acid [Clone VP13-607.1.D5]
Anti-Valproic Acid [Clone VP13-607.1.D5]
Product No.: 16806
Data
Valproic acid is primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. - -
- -
Antibody DetailsProduct DetailsReactive Species Valproic Acid Host Species Mouse Immunogen Valproic acid conjugated to KLH. Product Concentration Lot Specific Formulation This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added. State of Matter Liquid Product Preparation Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling This antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Mouse Monoclonal Antibody specific to Valproic Acid Background Valproic acid is primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It has recently been shown to protect against a seizure induced reduction in phosphatidylinositol (3,4,5)-trisphosphate (PIP3) as a potential therapeutic mechanism. In addition, its anticonvulsant effect has been attributed to the blockade of voltage dependent sodium channels and increased brain levels of gamma-aminobutyric acid (GABA). Valproic acid was first made in 1881 and came into medical use in 1962. It is on the World Health
Organization's List of Essential Medicines. Research Area Drugs References & CitationsTechnical Protocols Certificate of Analysis |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
